Dr Absar Khalid Mir (2024) “EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY”, Journal of Population Therapeutics and Clinical Pharmacology, 31(6), pp. 1059–1065. doi:10.53555/jptcp.v31i6.6611.